Skip to main content

7 Best Defense Stocks to Buy Now

The fiscal 2026 National Defense Authorization Act proposes $924.7 billion in U.S. military spending, a slight increase over 2025 spending levels. However, the Russia-Ukraine War, ongoing Middle East conflicts involving Israel, Iran and Hamas, and tensions between the U.S. and China regarding Taiwan may compel global governments to increase defense industry spending.

[Sign up for stock news with our Invested newsletter.]

At the same time, these geopolitical pressures could provide significant tailwinds for defense industry earnings. Defense stocks remain highly attractive for investors seeking stability, as these companies typically have predictable, multi-year government contracts. Morgan Stanley analysts have identified these seven top-tier defense stocks to buy in 2026:

Stock Implied change*
RTX Corp. (ticker: RTX) 17%
General Dynamics Corp. (GD) 17%
Northrop Grumman Corp. (NOC) 9%
Howmet Aerospace Inc. (HWM) -10%
TransDigm Group Inc. (TDG) 29%
L3Harris Technologies Inc. (LHX) 13%
Axon Enterprise Inc. (AXON) 77%

*From Feb. 13 close.

RTX Corp. (RTX)

RTX is the defense behemoth created by the 2020 merger of Raytheon and United Technologies. The company’s Collins and Pratt & Whitney subsidiaries are more focused on the commercial aerospace industry, but its Raytheon subsidiary develops advanced sensors and provides training, software and cybersecurity solutions for the U.S. intelligence community and the newly renamed Department of War. Analyst Kristine Liwag says RTX has strong tailwinds in both its commercial and defense businesses and will generate sustainable margin expansion and revenue growth. RTX is Liwag’s top aerospace industry stock pick. Morgan Stanley has an “overweight” rating and $235 price target for RTX stock, which closed at $200.06 on Feb. 13.

General Dynamics Corp. (GD)

General Dynamics is a diversified aerospace and defense company that produces a wide range of products, including Gulfstream jets, Abrams tanks and nuclear submarines. The majority of the company’s revenue comes from the U.S. government, particularly its large contracts with the Department of War. While operating margins were somewhat soft, Liwag says General Dynamics exceeded expectations on net income, revenue and operating cash flow in the most recent quarter. She says General Dynamics’ Marine sales have been particularly impressive, and its Combat Systems backlog is expanding. Morgan Stanley has an “overweight” rating and $408 price target for GD stock, which closed at $347.64 on Feb. 13.

Northrop Grumman Corp. (NOC)

Northrop Grumman is one of the world’s largest weapons and military technology producers. The company’s Defense Systems segment provides battle management and missile systems products and services, while its Mission Systems segment focuses on airborne sensors and networks, as well as other military and intelligence mission solutions. Liwag says Northrop has potential to secure several large government awards in 2026 related to the B-21, F/A-XX and Golden Dome projects, and the company will likely exceed its initial 2026 revenue growth guidance of 4.5%. Morgan Stanley has an “overweight” rating and $765 price target for NOC stock, which closed at $702.57 on Feb. 13.

[Read: Recession 2026: What to Watch and How to Prepare]

Howmet Aerospace Inc. (HWM)

Howmet Aerospace manufactures lightweight metal products, specializing in jet engine components, titanium structural parts, aerospace fastening systems and forged wheels. The company also provides defense solutions to its military partners, such as precision machining, integrated program management and metals expertise. Liwag says she was not surprised by the positive market reaction to Howmet’s superb fourth-quarter results. She says the strong quarter was driven by 32% growth in Gas Turbines revenue and 20% growth in Defense Aerospace revenue. In addition, Liwag says Howmet’s initial 2026 guidance is likely conservative. Morgan Stanley has an “overweight” rating and $225 price target for HWM stock, which closed at $250.21 on Feb. 13.

TransDigm Group Inc. (TDG)

TransDigm designs and manufactures original aircraft parts sold to manufacturers. The company also produces aftermarket replacement parts sold to commercial and military aircraft operators. In recent years, TransDigm has announced several significant buyouts, including acquiring SEI Industries, Raptor Scientific and the components and subsystems business of Communications & Power Industries. Liwag says TransDigm’s recent stock weakness is a buying opportunity for long-term investors, especially given its attractive valuation. Finally, its $10 billion in capital ready for deployment suggests TransDigm could soon announce another transformative acquisition. Morgan Stanley has an “overweight” rating and $1,660 price target for TDG stock, which closed at $1,286.67 on Feb. 13.

L3Harris Technologies Inc. (LHX)

L3Harris Technologies is an aerospace and defense company focused on technology-driven mission solutions. The company’s leading defense products include airborne ISR (intelligence, surveillance and reconnaissance) and electronic warfare systems, precision-guided munitions and propulsion products, communication systems, integrated vision solutions, and space and missile defense technologies. Liwag says L3Harris’ Mission Solutions business is positioned for durable double-digit annual revenue growth over the next several years. She says the company has essentially reinvented solid rocket motor production, creating a more efficient production model that emphasizes common components. Morgan Stanley has an “overweight” rating and $390 price target for LHX stock, which closed at $345.50 on Feb. 13.

Axon Enterprise Inc. (AXON)

Axon Enterprise is a law enforcement hardware and technology solutions provider. In addition to supplying body-worn cameras and virtual reality training to law enforcement, Axon’s military products include military body-worn cameras, drone technology, in-vehicle camera systems and digital management platforms. Analyst Meta Marshall says she is confident opportunities in drones, artificial intelligence, enterprise and international markets will support durable 25% to 30% annual growth for Axon over the next several years. Marshall says Axon’s recent acquisition of 9-1-1 platform Prepared is evidence of its expanding addressable market. Morgan Stanley has an “overweight” rating and $760 price target for AXON stock, which closed at $429.67 on Feb. 13.

More from U.S. News

6 of the Best AI ETFs to Buy for 2026

These Companies Are Being Boycotted Over Trump Policies

7 Best Silver ETFs to Buy

7 Best Defense Stocks to Buy Now originally appeared on usnews.com

Update 02/17/26: This story was published at an earlier date and has been updated with new information.

Map shows more than 2,200 measles cases across U.S. in 2025 outbreaks

▶ Watch Video: Measles cases climb in the U.S. after 2025 was worst year in decades In 2025, United States recorded the most measles cases in more than 30 years, Centers for Disease Control and Prevention data shows. A large share of the infections were connected to an outbreak in West Texas that led to the deaths of two children. The total number of cases nationwide topped 2.200 by the end of the year, with infections confirmed in at least 44 states. Measles is one of the most contagious infectious diseases, and in some cases, can cause severe infections in the lungs and brain that can lead to cognitive issues, deafness or death. But doctors and health officials say the vaccine, which is normally given as part of the combination measles-mumps-rubella (MMR) vaccine, is highly safe and effective.While most people's symptoms improve, about 1 in 5 unvaccinated people who get measles will be hospitalized. About 1 out of every 1,000 children with measles will develop brain swelling that can lead to brain damage, and up to 3 of every 1,000 children who become infected will die, the CDC says. The largest outbreak of the year was in West Texas, with over 760 confirmed infections before the state declared the outbreak officially over in August. A growing number of cases have also been reported in other states around the country. In South Carolina, dozens of students were quarantined in October due to an outbreak and the number of cases there ballooned to over 200 by the end of the year.The CBS News data team has tracked confirmed measles cases nationwide as new data is released by state health departments and the CDC. The Texas outbreak primarily affected children and teenagers, nearly all of whom were unvaccinated or had an unknown vaccination status. State and local health officials confirmed the first patient who died was an unvaccinated school-aged child, and the second was an unvaccinated 8-year-old girl. Neither of the children had underlying health conditions, the Texas health department said. New Mexico also reported the death of an adult with measles.The last measles death in the U.S. before that was in 2019, when a 37-year-old man died from measles complicated by meningitis in California, according to CDC data.Prior to 2025, the highest number of confirmed cases in the U.S. in recent years was 1,274 in 2019, driven by outbreaks in New York, California and Washington state, but most years the total has been much lower. Health experts point to lower vaccination rates as a reason for increases in preventable diseases like the measles.CDC data shows about 93% of kindergarteners in the U.S. were vaccinated against measles during the 2021-2022 school year and only 92.7% in the 2023-2024 school year. This is down from 95.2% during the 2019-2020 school year — a critical threshold to keep people safe. "When more than 95% of people in a community are vaccinated, most people are protected through community immunity (herd immunity)," the CDC states.Health and Human Services Secretary Robert F. Kennedy Jr., who has a history of making false and misleading claims about vaccines, voiced support for vaccination as the deadly outbreak spread in the Southwest."We encourage people to get the measles vaccine," Kennedy told CBS News chief medical correspondent Dr. Jon LaPook in an interview in April, marking the first time Kennedy has publicly urged people to get the measles vaccine since becoming HHS secretary.Asked by LaPook what the federal government's official position on the vaccine is, Kennedy reiterated, "The federal government's position, my position, is that people should get the measles vaccine," but added, "The government should not be mandating those." 
Read Next Story